Norway· NO-ID_0A850B69-46E6-4B23-980F-C48A15DCA98F
Insulin glulisin SA
A insulin glulisine product containing insulin glulisin, registered in Norway by Sykehusapoteket Oslo, Ullevål. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Insulin glulisine is registered in 14 of 19 countries.
Countries holding a registration under ATC A10AB06 (insulin glulisine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Insulin glulisine · ATC A10AB06
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Insulin glulisin
- Manufacturer
- Sykehusapoteket Oslo, Ullevål
- Country
- Norway (NO)
- ATC code
- A10AB06
- ATC class
- Insulin glulisine
- Defined daily dose
- 40 E, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_0A850B69-46E6-4B23-980F-C48A15DCA98F
- no_varenummer33314110 x 3.15
- gtin7072279001203
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
434 interactions on record for insulin glulisine.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Insulin glulisine · interactions on record
434 records
- 15 severe
- 368 moderate
- 50 minor
Most severe, free to view
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- PrednisoloneA07EA01moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Insulin glulisine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAPIDRASanofi-Aventis Deutschland GmbH, Frankfurt am Main
- United KingdomApidra 100units/ml solution for injection 10ml vialsSanofi
- SpainAPIDRA 100 UNIDADES/ml OPTICLIK SOLUCION INYECTABLE EN CARTUCHOSanofi-Aventis Deutschland Gmbh
- FinlandApidraSanofi-Aventis Deutschland GmbH
- CanadaAPIDRASANOFI-AVENTIS CANADA INC
- IcelandApidraSanofi-Aventis Deutschland GmbH
- ItalyAPIDRA*1 flaconcino SC 10 ml 100 U/mlSANOFI AVENTIS DEUTSCHL.GMBH
- Japanインスリングルリジン（遺伝子組換え）サノフィ
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Apidra, Apidra Solostar
- Liechtenstein · Apidra, Apidra Solostar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5d1ce2e-6087-4aa9-b010-d8cac966dc04 GET /v1/drugs/e5d1ce2e-6087-4aa9-b010-d8cac966dc04?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Insulin glulisin",
"merkevare_id": "ID_0A850B69-46E6-4B23-980F-C48A15DCA98F",
"name_form_strength": "Insulin glulisin SA inj, oppl 100 E/ml",
"prescription_group": "C"
}See everything about insulin glulisine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.